Beta Bionics Stock Crashes 37% as Fraud Probe Launched Over Growth Slowdown
Portnoy Law Firm investigates Beta Bionics for possible securities fraud after stock plummets 37% on disappointing Q4 2025 results showing user acquisition growth halved to 36%.
BBNXsecurities fraudclass action lawsuit